Did you know? You can suggest edits to improve this peptide information.
Overview
What is Glutathione?
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine, often called the body's 'master antioxidant.' Found in virtually every cell, it plays critical roles in neutralizing free radicals, detoxifying harmful substances, recycling other antioxidants (vitamins C and E), and supporting immune function. Glutathione levels decline with age and are depleted by stress, toxins, and certain diseases. Injectable forms bypass poor oral bioavailability to deliver glutathione directly to tissues.
Key Benefits
Direct delivery bypasses poor oral bioavailability. Rapidly increases plasma glutathione levels. Supports detoxification, immune function, and antioxidant defense systems.
Mechanism of Action
Glutathione directly neutralizes reactive oxygen species via its sulfhydryl group, conjugates toxins for excretion (Phase II detoxification), recycles vitamins C and E, and supports optimal lymphocyte function. The tripeptide's unique gamma peptide bond protects it from degradation by most peptidases.
Research Indications
Master Antioxidant Function
Glutathione is the body's primary intracellular antioxidant. Its sulfhydryl group donates electrons to neutralize free radicals and reactive oxygen species before they damage cells.
Antioxidant Recycling
Regenerates oxidized vitamins C and E back to their active forms, extending their protective capacity through the glutathione-ascorbate cycle.
Cellular Redox Balance
Maintains optimal GSH/GSSG ratio (typically >100:1 in healthy cells). This ratio is a key indicator of cellular health and oxidative stress status.
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing
Glutathione can be administered at any time of day. IV infusions are typically given in clinical settings. For home IM/SubQ injections, consistency in timing is more important than specific time of day.
How to Administer
Most glutathione injections come pre-mixed - no reconstitution required
If lyophilized: reconstitute with sterile water or bacteriostatic water per manufacturer instructions
Inspect solution - should be clear and colorless to slightly yellow
For IM/SubQ: Clean injection site with alcohol, draw prescribed dose
For IV: Administer as slow push or dilute in normal saline for infusion
IM injection: Deltoid or gluteal muscle at 90° angle
SubQ injection: Abdomen or thigh at 45° angle
Rotate injection sites to prevent tissue irritation
Quality Indicators
Licensed Compounding Pharmacy
Obtain from accredited compounding pharmacy (PCAB accreditation preferred) with proper sterility testing and quality controls.
Proper Form (Reduced GSH)
Ensure product contains reduced glutathione (GSH), not oxidized glutathione (GSSG), which must be converted by the body.
Clear Labeling
Product should clearly list concentration (e.g., 200mg/mL), lot number, expiration date, and proper storage requirements.
Healthcare Provider Supervision
IV administration should be performed by or under supervision of licensed healthcare provider who can manage potential adverse reactions.
pH Affects Comfort
Improperly buffered glutathione causes significant injection site stinging/pain. Quality formulations should be pH-adjusted to 6.0-7.0, close to physiological pH.
Short Half-Life
Plasma glutathione has a short half-life (~14 minutes). Benefits come from repeated administration and supporting endogenous production, not single doses.
Variable Bioavailability
Even with injection, cellular uptake varies. Some tissues take up glutathione better than others. Brain uptake is limited without intranasal route.
Unregulated Sources
Avoid products from non-licensed sources. Contamination, incorrect concentration, and degraded product are significant risks.
What to Expect
- Week 1-2: Minimal noticeable effects. Plasma glutathione levels increase acutely after each injection but have short half-life (~14 minutes for reduced GSH).
- Week 2-4: Some may notice improved energy or recovery. Detoxification processes are supported. Individual responses vary significantly.
- Week 4-8: Potential improvements in skin appearance, immune resilience, or neurological symptoms depending on indication. Effects are often subtle.
- Important: Glutathione is supportive therapy. Do not expect dramatic overnight changes. Benefits accumulate with consistent use over time.
- Note: Skin lightening effects (if any) are modest and temporary, requiring ongoing treatment to maintain.
Side Effects & Safety
- Generally well-tolerated when used appropriately
- Injection site pain/stinging is common if pH is not properly balanced (optimal pH 6.0-7.0) - quality formulations should be pH-buffered close to physiological levels
- Serious adverse events are rare but include anaphylaxis (especially IV) and potential hepatotoxicity with high doses
- Gastrointestinal discomfort (bloating, cramping) may occur
- May worsen asthma symptoms in susceptible individuals - avoid inhaled forms
- Long-term use may reduce zinc levels - consider periodic zinc supplementation
- Individuals with G6PD deficiency may be at risk for hemolysis with high doses
- DO NOT use during chemotherapy without oncologist approval - may interfere with treatment
- Avoid during pregnancy and breastfeeding - safety not established
- Philippine FDA has issued warnings about IV glutathione for cosmetic skin lightening
- Requires prescription from licensed healthcare provider
References
High-dose IV Glutathione Pharmacokinetics - Aebi et al.
Classic pharmacokinetic study demonstrating that IV glutathione significantly increases plasma levels but has a short half-life (~14 minutes), with rapid conversion to cysteine and other metabolites.
View Study (opens in new tab) →Glutathione in Parkinson's Disease - Substantia Nigra Depletion
Landmark study showing GSH levels were reduced by 40% in the substantia nigra of Parkinson's patients compared to controls, establishing the oxidative stress connection in PD pathogenesis.
View Study (opens in new tab) →Intranasal Glutathione Phase IIb Trial - Mischley et al.
Double-blind, placebo-controlled trial found intranasal glutathione increased brain GSH levels and showed mild motor improvement in Parkinson's patients, though placebo group also improved.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia